• 2 months 3 weeks ago Help us improve our website: http://t.co/vY9vRzmYRH! Please take our visitor survey: http://t.co/8gY0wRZtGx. Thank you...
  • 2 months 3 weeks ago 1st European Research Forum on Healthy Ageing: 03 Sept in Bxl. Policy makers, scientists, industrials: save the date! http://t.co/6TXrBI5rdt
  • 3 months 4 days ago Gender inequalities in health: a matter of policies according to @sophieproject http://t.co/TzwZzXko3g
  • 4 months 2 days ago 1/3 of cancer patients killed by 'fat-burning' process termed cachexia, @CNIO_Cancer researchers say http://t.co/GjfipsdG2R
  • 5 months 1 hour ago New EU research project @pneumonp aims to tackle antibiotic resistance via inhalable nano therapeutics #nanomedicine http://t.co/VQN9WHojG2
  • 5 months 2 weeks ago Urban renewal improves the health of neighbours in Barcelona according to EU-funded project @sophieproject http://t.co/F0mKCdPBZ5
  • 5 months 2 weeks ago Check this article on #CommHERE: how to spread the word about research and reach out beyond the scientific community http://t.co/VDcKVDEfcc
  • 6 months 2 weeks ago Scientists @CNIO_Cancer among the 40 most important global researchers http://t.co/Rc0hIsq6dN
  • 6 months 4 weeks ago 2nd workshop @CIBER_ISCIII to strengthen the EU‐LAC Health Research Cooperation http://t.co/93qLQObcQj
  • 8 months 2 weeks ago The European Symposium in Drug Synthesis @unisiena will take place on May 18-23. You can register until April 15!! http://t.co/V8kxQIev9S

Moodinflame

Professor Hemmo Drexhage

Prof. Hemmo Drexhage

Scientific coordinator of Moodinflame, based at Erasmus University Medical Centre in Rotterdam, the Netherlands

Research field

Immunology, Psychiatry

If you like this
If you want to know more
Research Profile

Who?

“A passion for medicine runs in my family: my three grown-up children all work in healthcare”, says Hemmo Drexhage, Professor of Medical Immunology at Erasmus University Medical Centre in the Netherlands. Drexhage published about 300 scientific articles and supervised more than 30 PhD students.

Why?

More than 33 million European citizens suffer from a mood disorder. Mood disorders have a devastating impact on the patient’s personal life. They also account for a high percentage of European healthcare costs. Developing tests and drugs will greatly improve our ability to diagnose and treat these serious disorders.

What?

Mood disorders like depression and bipolar disorder may result from inflammation of the brain. The aim of Moodinflame is to develop blood tests and brain scans to identify this inflammation in psychiatric patients. The scientists also want to develop therapies for mood disorders using anti-inflammatory medications.

How?

The Moodinflame consortium consists of 18 scientific groups from 10 European countries. The EU grant enables the 18 laboratories to battle this major health problem facing the European population by sharing their expertise, knowledge and technological skills.

Exploring the biological basis of psychiatric disease

In the Picture
In the Picture
Moodinflame website World Health Organization In Focus article 'Psychiatry moving forward' PDF versionPDF version
Image credits

Background image: Moodinflame

Portrait of the project coordinator: Moodinflame

Timeline (in chronological order): Moodinflame